-
ICD-10-CM Codes
›
-
Z00-Z99
›
-
Z77-Z99
›
-
Z79-
›
-
2023 ICD-10-CM Diagnosis Code Z79.81
2023 ICD-10-CM Diagnosis Code Z79.81
Long term (current) use of agents affecting estrogen receptors and estrogen levels
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
- Z79.81 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- Short description: Lng trm (crnt) use of agnt aff estrog recpt & estrog levels
- The 2023 edition of ICD-10-CM Z79.81 became effective on October 1, 2022.
- This is the American ICD-10-CM version of Z79.81 - other international versions of ICD-10 Z79.81 may differ.
Use AdditionalUse Additional Help
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation. In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere." Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code. "In diseases classified elsewhere" codes are never permitted to be used as first listed or principle diagnosis codes. They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition.
- code, if applicable, to identify:
- estrogen receptor positive status (
ICD-10-CM Diagnosis Code Z17.0
Estrogen receptor positive status [ER+]
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
- family history of breast cancer (
ICD-10-CM Diagnosis Code Z80.3
Family history of malignant neoplasm of breast
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
Applicable To- Conditions classifiable to C50.-
- genetic susceptibility to malignant neoplasm (cancer) (
ICD-10-CM Diagnosis Code Z15.0
Genetic susceptibility to malignant neoplasm
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Code First- , if applicable, any current malignant neoplasm (C00-C75, C81-C96)
Use Additional- code, if applicable, for any personal history of malignant neoplasm (Z85.-)
- personal history of breast cancer (
ICD-10-CM Diagnosis Code Z85.3
Personal history of malignant neoplasm of breast
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
Applicable To- Conditions classifiable to C50.-
- personal history of prostate cancer (
ICD-10-CM Diagnosis Code Z85.46
Personal history of malignant neoplasm of prostate
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Male Dx POA Exempt
- postmenopausal status (
ICD-10-CM Diagnosis Code Z78.0
Asymptomatic menopausal state
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Adult Dx (15-124 years) Female Dx POA Exempt
Applicable To- Menopausal state NOS
- Postmenopausal status NOS
Type 2 Excludes- symptomatic menopausal state (N95.1)
Code FirstCode First Help
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation. In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere." Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code. "In diseases classified elsewhere" codes are never permitted to be used as first listed or principle diagnosis codes. They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition.
Type 1 ExcludesType 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as Z79.81. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
The following code(s) above
Z79.81 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
Z79.81:
- Z00-Z99
2023 ICD-10-CM Range Z00-Z99
Factors influencing health status and contact with health servicesNote- Z codes represent reasons for encounters. A corresponding procedure code must accompany a Z code if a procedure is performed. Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00-Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways:
- (a) When a person who may or may not be sick encounters the health services for some specific purpose, such as to receive limited care or service for a current condition, to donate an organ or tissue, to receive prophylactic vaccination (immunization), or to discuss a problem which is in itself not a disease or injury.
- (b) When some circumstance or problem is present which influences the person's health status but is not in itself a current illness or injury.
- Z77-Z99
2023 ICD-10-CM Range Z77-Z99
Persons with potential health hazards related to family and personal history and certain conditions influencing health statusCode Also- any follow-up examination (Z08-Z09)
- Z79
ICD-10-CM Diagnosis Code Z79
Long term (current) drug therapy
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Code Also- any therapeutic drug level monitoring (Z51.81)
Includes- long term (current) drug use for prophylactic purposes
Type 2 Excludes- drug abuse and dependence (F11-F19)
- drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
Code annotations containing back-references to Z79.81:
ICD-10-CM Codes Adjacent To Z79.81
Z79.624 Long term (current) use of inhibitors of nucleotide synthesis
Z79.63 Long term (current) use of chemotherapeutic agent
Z79.630 Long term (current) use of alkylating agent
Z79.631 Long term (current) use of antimetabolite agent
Z79.632 Long term (current) use of antitumor antibiotic
Z79.633 Long term (current) use of mitotic inhibitor
Z79.634 Long term (current) use of topoisomerase inhibitor
Z79.64 Long term (current) use of myelosuppressive agent
Z79.69 Long term (current) use of other immunomodulators and immunosuppressants
Z79.8 Other long term (current) drug therapy
Z79.81
Long term (current) use of agents affecting estrogen receptors and estrogen levels
Z79.810 Long term (current) use of selective estrogen receptor modulators (SERMs)
Z79.811 Long term (current) use of aromatase inhibitors
Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels
Z79.82 Long term (current) use of aspirin
Z79.83 Long term (current) use of bisphosphonates
Z79.84 Long term (current) use of oral hypoglycemic drugs
Z79.85 Long-term (current) use of injectable non-insulin antidiabetic drugs
Z79.89 Other long term (current) drug therapy
Z79.890 Hormone replacement therapy
Z79.891 Long term (current) use of opiate analgesic
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
